Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Molecular Imaging for Thyrotoxicosis and Thyroid Nodules

Luca Giovanella, Anca Avram and Jerome Clerc
Journal of Nuclear Medicine July 2021, 62 (Supplement 2) 20S-25S; DOI: https://doi.org/10.2967/jnumed.120.246017
Luca Giovanella
1Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland;
2Clinic for Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anca Avram
3Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome Clerc
4Department of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, DMU Imagina, University of Paris, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Sonographically suspicious left thyroid nodule in patient with normal TSH level (i.e., 1.24 mUI/L). FNA biopsy demonstrated follicular neoplasm (Bethesda IV cytology). MPUS shows slightly irregular hypoechoic nodule (A) with increased vascularization (B). 123I TS depicted AFTN (C) excluding malignancy.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Diagnostic work-up of thyroid nodules. Local TSH threshold is mainly based on local iodine supply: in general, levels below lower limit of reference range (i.e., <0.3–0.4 mUI/L) are adopted in countries with adequate iodine supply whereas higher values are suggested in countries with previous or current iodine deficiency (up to 2.5–3.0 mUI/L) (1,44–48).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Cytologically indeterminate thyroid nodules at FNA. TS demonstrates photopenic defect on 99mTc-pertechnetate scan consistent with hypofunctioning nodule within right thyroid lobe (A) with uptake and retention of 99mTc-sestaMIBI (B). Histology: papillary thyroid cancer, follicular variant.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Chronically fluctuating low TSH values in woman with no biologic diagnosis for autoimmune thyroid disease (i.e., negative TRAb and TPOAb) and unremarkable MPUS (not shown). (A) Baseline TS: normal 123I thyroid uptake (13.1%) and homogeneous tracer distribution. (B) Suppressed TS: not suppressed 123I thyroid uptake (9.2%) and well-contrasted thyroid image after administration of liothyronine (50 μg/d) for 5 d demonstrate diffuse thyroid autonomy.

Tables

  • Figures
    • View popup
    TABLE 1

    Thyrotoxicosis: Etiology, Pathophysiology, and Relevant Points for Differential Diagnosis

    DiseaseEtiologyPathophysiologyLaboratoryThyroid scan and RAIUMPUS
    GDAutoimmuneTSH-R stimulationTSH, fT4/fT3; TRAb+ 95%–99%; TPOAb+ ∼60%Uptake (diffuse)Hypoechoic pattern; Vascular flow (diffuse)
     GD variantsAutoimmuneMixed GD/AITDTSH, fT4/fT3; TRAb+ 95%–99%; TPOAb+ ∼80%Uptake (heterogeneous)Hypoechoic pattern; Vascular flow (diffuse)
    AutoimmuneGD+hypofunctioning nodule(s)TSH, fT4/fT3; TRAb+ 95%–99%; TPOAb+ ∼60%Uptake (diffuse) with cold nodule(s)Hypoechoic diffuse variable for nodules
    AutoimmuneGD+hyperfunctioning noduleTSH, fT4/fT3; TRAb+ 95%–99%; TPOAb+ ∼60%Marine-Lenhardt syndromeAspecific pattern
    TFASomatic mutationsOveractive TSH-R; overactive Gsα-subunitTSH, fT4/fT3; no specific biomarkersTSH-independent thyroid uptakeAspecific pattern
     TFA variantsSomatic mutationsUnifocal autonomyTSH, fT4/fT3; no specific biomarkersTSH-independent unifocal uptakeAspecific pattern
    Somatic mutationsMultifocal autonomyTSH, fT4/fT3; no specific biomarkersTSH-independent multifocal uptakesAspecific pattern
    Somatic mutationsDisseminated autonomyTSH, fT4/fT3; no specific biomarkersTSH-independent diffuse uptakeAspecific pattern
    Subacute thyroiditisViralInflammatory destructionTSH, fT4/fT3; ESR/CRP; TPOAb+ infrequentAbsent to uptake (early phase)Hypoechoic; irregular vascular flow
    Painless thyroiditisAutoimmuneTransient immuno-mediated cytolysisTSH, fT4/fT3; TPOAb+ 95%–99%; normal ESR/CRPAbsent to uptake (early phase)Hypoechoic; normal to vascular flow
    Drug inducedIodine overloadAIH type 1: pathologic escape from Wolff-Chaickoff effect)TSH, fT4/fT3; ioduriaUptake with visible contrastAspecific pattern
    Iodine overloadAIH type 2: iodine-induced destructive thyroiditisTSH, fT4/fT3; ioduriaAbsent uptakeHypoechoic; irregular vascular flow
    TKI, ICPIDestructive thyroiditisTSH, fT4/fT3; TPOAb+ variableAbsent to uptakeAspecific pattern
    Factitious thyrotoxicosisT4, T3, TH analogsTSH, fT4/fT3; thyroglobulinAbsent to uptakeNormal to vascular flow
    TumorsStruma ovariiOvarian TH biosynthesisTSH, fT4/fT3; thyroglobulinSuppressed to uptakeNormal thyroid pelvic US: ovarian tumor
    Thyroid cancerFunctioning metastasisTSH, fT4/fT3; thyroglobulinConsider 131I-WBS (thyroid suppressed)Suspicious lymph nodes and thyroid nodules
    Germinal tumorsβHCG overproductionTSH, fT4/fT3; βHCGNormal to diffuse uptakeNormal to vascular flow
    CentralPituitary resistanceTHR mutation (TRβ)Normal to TSH; normal to fT4/fT3Normal to diffuse uptakeNormal to vascular flow
    Pituitary adenomaTSH-secreting tumorNormal to TSH; normal to fT4/fT3; TSH α-subunitNormal to diffuse uptakeNormal to vascular flow
    • AIH = amiodarone-induced hyperthyroidism; AITD = autoimmune thyroid diseases; CRP = C-reactive protein; ESR = erythrocyte sedimentation rate; fT3 = free triiodothyronine; fT4 = free thyroxine; GD = Graves disease; HCG = human chorionic gonadotropin; ICPI = immune checkpoint inhibitor; TFA = thyroid functional autonomy; TH = thyroid hormone; THR = thyroid hormone receptor; TKI = thyrosine kinase inhibitors; TPOAb = thyroperoxidase antibody; TRAb = TSH-receptor antibody; TRβ = thyroid receptor β; TSH = thyroid stimulating hormone; TSH-R = TSH-receptor; T4 = thyroxine; T3 = liothyronine; US = ultrasound; WBS = whole-body scintigraphy.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (Supplement 2)
Journal of Nuclear Medicine
Vol. 62, Issue Supplement 2
July 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
Luca Giovanella, Anca Avram, Jerome Clerc
Journal of Nuclear Medicine Jul 2021, 62 (Supplement 2) 20S-25S; DOI: 10.2967/jnumed.120.246017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
Luca Giovanella, Anca Avram, Jerome Clerc
Journal of Nuclear Medicine Jul 2021, 62 (Supplement 2) 20S-25S; DOI: 10.2967/jnumed.120.246017
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • THYROID MOLECULAR IMAGING: BASIC CONCEPTS
    • THYROTOXICOSIS
    • THYROID NODULES
    • CONCLUSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Role of [99mTc]Tc-Sestamibi in Functional Imaging of the Iodine-Loaded Thyroid Gland
  • Google Scholar

More in this TOC Section

  • [11C]ZTP-1: An Effective Short-Lived Radioligand for PET of Rat and Monkey Brain Phosphodiesterase Type 4 Subtype B
  • Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
Show more Basic Science Investigation

Similar Articles

Keywords

  • hyperthyroidism
  • Molecular imaging
  • thyroid nodules
  • thyroid functional autonomy
SNMMI

© 2025 SNMMI

Powered by HighWire